These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10940305)

  • 1. The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway.
    Yusta B; Boushey RP; Drucker DJ
    J Biol Chem; 2000 Nov; 275(45):35345-52. PubMed ID: 10940305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase.
    Yusta B; Estall J; Drucker DJ
    J Biol Chem; 2002 Jul; 277(28):24896-906. PubMed ID: 11978789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
    Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
    J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphatidylinositol 3-kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis.
    Madge LA; Li JH; Choi J; Pober JS
    J Biol Chem; 2003 Jun; 278(23):21295-306. PubMed ID: 12663669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways.
    Koehler JA; Yusta B; Drucker DJ
    Mol Endocrinol; 2005 Feb; 19(2):459-73. PubMed ID: 15471943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor.
    Boushey RP; Yusta B; Drucker DJ
    Cancer Res; 2001 Jan; 61(2):687-93. PubMed ID: 11212269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
    Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
    Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
    Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
    J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
    Hui H; Nourparvar A; Zhao X; Perfetti R
    Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of glucagon-like peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells.
    Koehler JA; Drucker DJ
    Diabetes; 2006 May; 55(5):1369-79. PubMed ID: 16644694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic nucleotides suppress tumor necrosis factor alpha-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation.
    Li J; Yang S; Billiar TR
    J Biol Chem; 2000 Apr; 275(17):13026-34. PubMed ID: 10777606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signaling.
    Estall JL; Drucker DJ
    J Nutr; 2003 Nov; 133(11):3708-11. PubMed ID: 14608100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-dependent apoptosis and -independent poly(ADP-ribose) polymerase cleavage induced by transforming growth factor beta1.
    Yang Y; Zhao S; Song J
    Int J Biochem Cell Biol; 2004 Feb; 36(2):223-34. PubMed ID: 14643888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of various kinases in staurosporine induced apoptosis of RAW 264.7 cells.
    Yamaki K; Hong J; Hiraizumi K; Ahn JW; Zee O; Ohuchi K
    J Pharm Pharmacol; 2002 Nov; 54(11):1535-44. PubMed ID: 12495557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa.
    Walsh NA; Yusta B; DaCambra MP; Anini Y; Drucker DJ; Brubaker PL
    Endocrinology; 2003 Oct; 144(10):4385-92. PubMed ID: 12960094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
    Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
    Huisman C; Ferreira CG; Bröker LE; Rodriguez JA; Smit EF; Postmus PE; Kruyt FA; Giaccone G
    Clin Cancer Res; 2002 Feb; 8(2):596-606. PubMed ID: 11839682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP activation of the extracellular signal-regulated kinases 1 and 2: implications for intestinal cell survival through the transient inhibition of apoptosis.
    Rudolph JA; Poccia JL; Cohen MB
    J Biol Chem; 2004 Apr; 279(15):14828-34. PubMed ID: 14744867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets.
    Burrin DG; Stoll B; Guan X; Cui L; Chang X; Holst JJ
    Endocrinology; 2005 Jan; 146(1):22-32. PubMed ID: 15486229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.
    Estall JL; Yusta B; Drucker DJ
    Mol Biol Cell; 2004 Aug; 15(8):3673-87. PubMed ID: 15169869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.